Serological biomarker testing helps avoiding unnecessary endoscopies in obese patients before bariatric surgery.

Jaanus SuumannToomas SillakiviŽivile RiispereKari SyrjänenPentti SipponenÜlle KirsimägiAnts Peetsalu

Published in: BMC obesity (2018)

The normal biomarker profile is an excellent surrogate for healthy stomach, implicating that pre-operative EGDS could have been avoided in 31% of our asymptomatic bariatric surgery patients who had the normal biomarker profile.

Keyphrases

bariatric surgery
obese patients
weight loss
roux en y gastric bypass
gastric bypass